| scholarly article | Q13442814 |
| P50 | author | Michael J Pencina | Q37382178 |
| Cecile Janssens | Q58477081 | ||
| Ralph B. D'Agostino Sr. | Q59209521 | ||
| Karol M Pencina | Q91565844 | ||
| Philip Greenland | Q93019727 | ||
| P2860 | cites work | Prediction of Coronary Heart Disease Using Risk Factor Categories | Q22241923 |
| Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) | Q27860959 | ||
| Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study | Q28257557 | ||
| Use of multiple biomarkers to improve the prediction of death from cardiovascular causes | Q28280099 | ||
| General cardiovascular risk profile for use in primary care: the Framingham Heart Study | Q29614189 | ||
| Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond | Q29614697 | ||
| Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association | Q30434464 | ||
| Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study | Q30491056 | ||
| Coronary artery calcium score and risk classification for coronary heart disease prediction | Q34552221 | ||
| Decision curve analysis: a novel method for evaluating prediction models | Q34581068 | ||
| Multiple biomarkers for the prediction of first major cardiovascular events and death | Q34593507 | ||
| Genotype score in addition to common risk factors for prediction of type 2 diabetes | Q34884376 | ||
| Assessing the value of risk predictions by using risk stratification tables | Q34969023 | ||
| Assessment of claims of improved prediction beyond the Framingham risk score | Q35015499 | ||
| Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community | Q35575045 | ||
| Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker | Q35754449 | ||
| Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers | Q35927436 | ||
| Novel metrics for evaluating improvement in discrimination: net reclassification and integrated discrimination improvement for normal variables and nested models | Q35927439 | ||
| Index for rating diagnostic tests | Q39605675 | ||
| Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors | Q39605793 | ||
| Use and misuse of the receiver operating characteristic curve in risk prediction | Q40241086 | ||
| Decision curve analysis: a discussion | Q41976258 | ||
| A risk score for predicting near-term incidence of hypertension: the Framingham Heart Study. | Q51896792 | ||
| Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. | Q51995722 | ||
| Equivalence of improvement in area under ROC curve and linear discriminant analysis coefficient under assumption of normality | Q57313402 | ||
| Strengthening the reporting of genetic risk prediction studies: the GRIPS statement | Q59379504 | ||
| Projecting individualized probabilities of developing breast cancer for white females who are being examined annually | Q69396132 | ||
| Visualizing and assessing discrimination in the logistic regression model | Q84577791 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 473-481 | |
| P577 | publication date | 2012-08-08 | |
| P1433 | published in | American Journal of Epidemiology | Q4744243 |
| P1476 | title | Interpreting incremental value of markers added to risk prediction models | |
| P478 | volume | 176 |
| Q61816793 | A Direct Comparison of the Relationship of Epigenetic Aging and Epigenetic Substance Consumption Markers to Mortality in the Framingham Heart Study |
| Q61802679 | A New Insight Into Missing Data in Intensive Care Unit Patient Profiles: Observational Study |
| Q50318034 | A methodology review on the incremental prognostic value of computed tomography biomarkers in addition to Framingham risk score in predicting cardiovascular disease: the use of association, discrimination and reclassification |
| Q90662115 | A multimethod screening approach for pediatric depression onset: An incremental validity study |
| Q47908195 | ACC/AHA guidelines superior to ESC/EAS guidelines for primary prevention with statins in non-diabetic Europeans: the Copenhagen General Population Study |
| Q57614504 | Accuracy of ultrasound for predicting pathologic response during neoadjuvant therapy for breast cancer |
| Q34517195 | Adipocytokines, hepatic and inflammatory biomarkers and incidence of type 2 diabetes. the CoLaus study |
| Q35114808 | Alternative performance measures for prediction models |
| Q28551639 | An Original Stepwise Multilevel Logistic Regression Analysis of Discriminatory Accuracy: The Case of Neighbourhoods and Health |
| Q33926791 | An assessment of the relationship between clinical utility and predictive ability measures and the impact of mean risk in the population |
| Q39045940 | Apolipoprotein B improves risk assessment of future coronary heart disease in the Framingham Heart Study beyond LDL-C and non-HDL-C. |
| Q33996015 | Applying measures of discriminatory accuracy to revisit traditional risk factors for being small for gestational age in Sweden: a national cross-sectional study |
| Q41238135 | Assessing the incremental value of blood oxygen saturation (SpO(2)) in the miniPIERS (Pre-eclampsia Integrated Estimate of RiSk) Risk Prediction Model |
| Q38829854 | Association of Physical Function with Clinical and Subclinical Brain Disease: The Framingham Offspring Study |
| Q37457712 | Association of novel biomarkers of cardiovascular stress with left ventricular hypertrophy and dysfunction: implications for screening |
| Q34644160 | Association of urinary KIM-1, L-FABP, NAG and NGAL with incident end-stage renal disease and mortality in American Indians with type 2 diabetes mellitus |
| Q53029825 | Autologous GVHD? |
| Q36081608 | Automated Quantitative Plaque Burden from Coronary CT Angiography Noninvasively Predicts Hemodynamic Significance by using Fractional Flow Reserve in Intermediate Coronary Lesions |
| Q34342621 | B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: the CHARGE-AF Consortium of community-based cohort studies |
| Q39998217 | Bayesian reclassification statistics for assessing improvements in diagnostic accuracy. |
| Q33981208 | Beyond Self-Reports: Changes in Biomarkers as Predictors of Mortality |
| Q38113457 | Biomarkers for incident CKD: a new framework for interpreting the literature |
| Q91761635 | Biomarkers improve prediction of 30-day unplanned readmission or mortality after paediatric congenital heart surgery |
| Q90477779 | Body mass index versus bioelectrical impedance analysis for classifying physical function impairment in a racially diverse cohort of midlife women: the Study of Women's Health Across the Nation (SWAN) |
| Q37682214 | Brain imaging and cognitive predictors of stroke and Alzheimer disease in the Framingham Heart Study |
| Q40406413 | Brain natriuretic peptide usefulness in very elderly dyspnoeic patients: the BED study |
| Q36905510 | Cardiovascular Disease Risk Assessment: Insights from Framingham |
| Q47568245 | Cardiovascular Outcomes According to Urinary Albumin and Kidney Disease in Patients With Type 2 Diabetes at High Cardiovascular Risk: Observations From the SAVOR-TIMI 53 Trial. |
| Q37424605 | Cardiovascular disease risk prediction in women: is there a role for novel biomarkers? |
| Q48178771 | Cardiovascular risk prediction: Can Systematic Coronary Risk Evaluation (SCORE) be improved by adding simple risk markers? Results from the Copenhagen City Heart Study |
| Q36956679 | Carotid Intima-Media Thickness and Arterial Stiffness and the Risk of Atrial Fibrillation: The Atherosclerosis Risk in Communities (ARIC) Study, Multi-Ethnic Study of Atherosclerosis (MESA), and the Rotterdam Study |
| Q26738845 | Carotid Stiffness: A Novel Cerebrovascular Disease Risk Factor |
| Q47206216 | Cell-free DNA as a biomarker in stroke: Current status, problems and perspectives |
| Q34324812 | Charting a roadmap for heart failure biomarker studies |
| Q48270483 | Clinical risk reclassification at 10 years |
| Q36379969 | Clinical utility in evaluation of risk models |
| Q36489222 | Clinically relevant measures of fit? A note of caution |
| Q88540008 | Common measures of chronic kidney disease improve vascular risk prediction |
| Q37517121 | Comparing the Predictive Ability of Prognostic Models in Ischemic Stroke; Derivation, Validation, and Discrimination Beyond the ROC Curve |
| Q34389051 | Comparison of lifestyle-based and traditional cardiovascular disease prediction in a multiethnic cohort of nonsmoking women |
| Q30371657 | Complex signals bioinformatics: evaluation of heart rate characteristics monitoring as a novel risk marker for neonatal sepsis |
| Q37550749 | Construction and analysis of multiparameter prognostic models for melanoma outcome |
| Q47668889 | Coronary Artery Calcium Distribution Is an Independent Predictor of Incident Major Coronary Heart Disease Events: Results From the Framingham Heart Study |
| Q37076136 | Coronary Computed Tomography (CT) Angiography as a Predictor of Cardiac and Noncardiac Vascular Events in Asymptomatic Type 2 Diabetics: A 7-Year Population-Based Cohort Study |
| Q46302892 | Cumulative Intracranial Tumor Volume Augments the Prognostic Value of Diagnosis-Specific Graded Prognostic Assessment Model for Survival in Patients with Melanoma Cerebral Metastases |
| Q91972136 | Derivation and External Validation of a Scoring System for Predicting Fracture Risk After Ischemic Stroke in a Canadian Cohort |
| Q41728784 | Derivation and internal validation of an expanded cardiovascular risk prediction score for rheumatoid arthritis: a Consortium of Rheumatology Researchers of North America Registry Study |
| Q92495145 | Development and validation of a 5-year mortality prediction model using regularized regression and Medicare data |
| Q92859090 | Development of a predictive risk model for school readiness at age 3 years using the UK Millennium Cohort Study |
| Q58197552 | Diagnostic and prognostic value of autoantibodies anti-apolipoprotein A-1 and anti-phosphorylcholine in acute non-ST elevation myocardial infarction |
| Q40551297 | Differential incremental value of ultrasound carotid intima-media thickness, carotid plaque, and cardiac calcium to predict angiographic coronary artery disease across Framingham risk score strata in the APRES multicentre study |
| Q99633761 | Early identification of preterm neonates at birth with a Tablet App for the Simplified Gestational Age Score (T-SGAS) when ultrasound gestational age dating is unavailable: A validation study |
| Q54258316 | Echocardiography in Hypertension in the Era of Risk Stratification and Personalized Medicine. |
| Q30277036 | Entropy of cardiac repolarization predicts ventricular arrhythmias and mortality in patients receiving an implantable cardioverter-defibrillator for primary prevention of sudden death |
| Q50923560 | Estimated glomerular filtration rate better predicts 30-day mortality after non-cardiac surgery than serum creatinine: a retrospective analysis of 92,888 patients. |
| Q47160901 | Estimating 1-Year Mortality for High-Risk Primary Care Patients Using the "Surprise" Question |
| Q35006867 | Evaluation of the Wii Balance Board for walking aids prediction: proof-of-concept study in total knee arthroplasty |
| Q48275325 | Evaluation of the incremental prognostic value of the combination of CYP2C19 poor metabolizer status and ABCB1 3435 TT polymorphism over conventional risk factors for cardiovascular events after drug-eluting stent implantation in East Asians. |
| Q30938157 | Explained variation for recurrent event data. |
| Q34421217 | Fibroblast growth factor-23, cardiovascular prognosis, and benefit of angiotensin-converting enzyme inhibition in stable ischemic heart disease |
| Q42138242 | Further insight into the incremental value of new markers: the interpretation of performance measures and the importance of clinical context |
| Q47568956 | Genetic and clinic predictors of new onset diabetes mellitus after transplantation |
| Q38231838 | Graphical assessment of incremental value of novel markers in prediction models: From statistical to decision analytical perspectives. |
| Q55512961 | Hematuria as a risk factor for progression of chronic kidney disease and death: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study. |
| Q28546453 | High serum β-lactams specific/total IgE ratio is associated with immediate reactions to β-lactams antibiotics |
| Q35599099 | High-sensitivity cardiac troponin T and the risk of incident atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study. |
| Q26748660 | How to Develop, Validate, and Compare Clinical Prediction Models Involving Radiological Parameters: Study Design and Statistical Methods |
| Q64121066 | I-Boost: an integrative boosting approach for predicting survival time with multiple genomics platforms |
| Q38972849 | Identifying the ideal metric of proteinuria as a predictor of renal outcome in idiopathic glomerulonephritis |
| Q89514343 | Impact of a posttraumatic cerebral infarction on outcome in patients with TBI: the Italian multicenter cohort INCEPT study |
| Q33866958 | Improved risk stratification in prevention by use of a panel of selected circulating microRNAs |
| Q58109412 | Improving long-term prediction of first cardiovascular event: The contribution of family history of coronary heart disease and social status |
| Q46694482 | Improving the Prognostic Value of Disease-Specific Graded Prognostic Assessment Model for Renal Cell Carcinoma by Incorporation of Cumulative Intracranial Tumor Volume. |
| Q36218531 | Improving the analysis and modeling of substance use. |
| Q49989927 | Increased Aortic Diameters on Multidetector Computed Tomographic Scan Are Independent Predictors of Incident Adverse Cardiovascular Events: The Framingham Heart Study |
| Q98830214 | Incremental prognostic value of a novel metabolite-based biomarker score in congestive heart failure patients |
| Q34511085 | Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancer |
| Q41104088 | Insulin-Like Growth Factor Binding Protein 4 Fragments Provide Incremental Prognostic Information on Cardiovascular Events in Patients With ST-Segment Elevation Myocardial Infarction |
| Q47558618 | Integrated prediction of lesion-specific ischaemia from quantitative coronary CT angiography using machine learning: a multicentre study |
| Q34133250 | Is there a role for coronary artery calcium scoring for management of asymptomatic patients at risk for coronary artery disease?: Clinical risk scores are sufficient to define primary prevention treatment strategies among asymptomatic patients |
| Q33974695 | Key concepts and limitations of statistical methods for evaluating biomarkers of kidney disease |
| Q90250326 | Lipoprotein(a) and Cardiovascular Risk Prediction Among Women |
| Q39480732 | Low serum adiponectin levels in childhood and adolescence predict increased intima-media thickness in adulthood. The Cardiovascular Risk in Young Finns Study |
| Q36152722 | Metabolic syndrome does not improve the prediction of 5-year cardiovascular disease and total mortality over standard risk markers. Prospective population based study |
| Q45158580 | Model for End-Stage Liver Disease score predicts mortality in critically ill cirrhotic patients |
| Q35070627 | Multilocus genetic risk scores for venous thromboembolism risk assessment |
| Q37230510 | N-Terminal Prosomatostatin as a Risk Marker for Cardiovascular Disease and Diabetes in a General Population |
| Q35054042 | NT-proBNP best predictor of cardiovascular events and cardiovascular mortality in secondary prevention in very old age: the Leiden 85-plus Study |
| Q34682031 | NT-proBNP linking low-moderately impaired renal function and cardiovascular mortality in diabetic patients: the population-based Casale Monferrato Study |
| Q89181684 | Net reclassification improvement with serial biomarkers and bed-sided spirometry to early predict the need of organ support during the early post-transplantation in-hospital stay in allogeneic HCT recipients |
| Q46091841 | Net reclassification improvement: a link between statistics and clinical practice. |
| Q47409931 | Net reclassification index at event rate: properties and relationships |
| Q37569098 | Net reclassification indices for evaluating risk prediction instruments: a critical review |
| Q37696697 | Net risk reclassification p values: valid or misleading? |
| Q38216483 | New risk markers for cardiovascular prevention |
| Q58737938 | Non-invasive detection of coronary inflammation using computed tomography and prediction of residual cardiovascular risk (the CRISP CT study): a post-hoc analysis of prospective outcome data |
| Q37061256 | Novel genetic markers improve measures of atrial fibrillation risk prediction |
| Q36489212 | Pencina et al. respond to "The incremental value of new markers" and "Clinically relevant measures? A note of caution". |
| Q47205309 | Performance of the Net Reclassification Improvement for Non-nested Models and a Novel Percentile-based Alternative. |
| Q47692611 | Plasma DNA methylation marker and hepatocellular carcinoma risk prediction model for the general population |
| Q35185694 | Plasma amyloid-β and risk of Alzheimer's disease in the Framingham Heart Study |
| Q54600478 | Plasma biomarkers improve prediction of diabetic kidney disease in adults with type 1 diabetes over a 12-year follow-up: CACTI study. |
| Q34718616 | Plasma triglycerides predict incident albuminuria and progression of coronary artery calcification in adults with type 1 diabetes: the Coronary Artery Calcification in Type 1 Diabetes Study |
| Q30841395 | Postoperative 30-day mortality in patients undergoing surgery for colorectal cancer: development of a prognostic model using administrative claims data. |
| Q36097529 | Pre-Transplant Cardiovascular Risk Factors Affect Kidney Allograft Survival: A Multi-Center Study in Korea |
| Q27022352 | Precocious cervical ripening as a screening target to predict spontaneous preterm delivery among asymptomatic singleton pregnancies: a systematic review |
| Q52659586 | Predicting Teen Dating Violence Perpetration. |
| Q33914115 | Predicting red blood cell transfusion in hospitalized patients: role of hemoglobin level, comorbidities, and illness severity |
| Q30982361 | Predictive value of semi-quantitative MRI-based scoring systems for future knee replacement: data from the osteoarthritis initiative |
| Q36902669 | Predictors for mortality from respiratory failure in a general population |
| Q58114958 | Primary Care Visit Regularity and Patient Outcomes: an Observational Study |
| Q57296523 | Prognostic Importance of Cumulative Intracranial Tumor Volume (CITV) in Gastrointestinal (GI) Brain Metastasis Patients Treated with Stereotactic Radiosurgery |
| Q35921040 | Prognostic Importance of Impaired Systolic Function in Heart Failure With Preserved Ejection Fraction and the Impact of Spironolactone |
| Q36770851 | Prognostic Value of Tubulointerstitial Lesions, Urinary N-Acetyl-β-d-Glucosaminidase, and Urinary β2-Microglobulin in Patients with Type 2 Diabetes and Biopsy-Proven Diabetic Nephropathy |
| Q104508252 | Prognostic and therapeutic considerations of antibodies against c-ter apolipoprotein A-1 in the general population |
| Q40451725 | Prognostic durability of liver fibrosis tests and improvement in predictive performance for mortality by combining tests. |
| Q92058066 | Quantifying the added value of new biomarkers: how and how not |
| Q24289453 | Quantifying the value of biomarkers for predicting mortality |
| Q52957005 | Quantitative plaque features from coronary computed tomography angiography to identify regional ischemia by myocardial perfusion imaging. |
| Q36490447 | Racial Differences in the Performance of Existing Risk Prediction Models for Incident Type 2 Diabetes: The CARDIA Study |
| Q35620363 | Recalibration and validation of the Charlson comorbidity index in Korean incident hemodialysis patients |
| Q33992404 | Recent BRCAPRO upgrades significantly improve calibration |
| Q42369456 | Reconsidering lactate as a sepsis risk biomarker |
| Q97425290 | Refining prediction of major bleeding on antiplatelet treatment after transient ischaemic attack or ischaemic stroke |
| Q36054342 | Relation of Combined Non-High-Density Lipoprotein Cholesterol and Apolipoprotein B With Atherosclerosis in Adults With Type 1 Diabetes Mellitus |
| Q33754583 | Risk stratification in critically ill patients: GDF-15 scores in adult respiratory distress syndrome |
| Q61851205 | Sample size considerations and predictive performance of multinomial logistic prediction models |
| Q37594556 | Selection criteria for lung-cancer screening |
| Q54384558 | Sensitivity and specificity can change in opposite directions when new predictive markers are added to risk models. |
| Q40189389 | Serum Levels of 1,5-Anhydroglucitol and Risk of Incident End-Stage Renal Disease |
| Q93349652 | Serum Uromodulin Predicts Less Coronary Artery Calcification and Diabetic Kidney Disease Over 12 Years in Adults With Type 1 Diabetes: The CACTI Study |
| Q37618158 | Serum prealbumin and its changes over time are associated with mortality in acute kidney injury |
| Q31165772 | Serum uric acid predicts vascular complications in adults with type 1 diabetes: the coronary artery calcification in type 1 diabetes study |
| Q50053888 | Sex differences in impact of coronary artery calcification to predict coronary artery disease |
| Q39018796 | Simple Scoring System to Predict In-Hospital Mortality After Surgery for Infective Endocarditis |
| Q41357862 | Soluble ST2 predicts outcome and hemorrhagic transformation after acute stroke |
| Q36543068 | Structural Predictors of Loss of Renal Function in American Indians with Type 2 Diabetes |
| Q37103951 | Suboptimal specificity of Xpert MTB/RIF among treatment-experienced patients |
| Q89231879 | Sudomotor dysfunction independently predicts incident cardiovascular-renal events and all-cause death in type 2 diabetes: the Joint Asia Diabetes Evaluation register |
| Q45940622 | Superior Prognostic Value of Cumulative Intracranial Tumor Volume Relative to Largest Intracranial Tumor Volume Stereotactic Radiosurgery-Treated Brain Metastasis Patients. |
| Q37540081 | Survival Regression Modeling Strategies in CVD Prediction |
| Q35013380 | Tailoring the implementation of new biomarkers based on their added predictive value in subgroups of individuals |
| Q36134230 | The 82-plex plasma protein signature that predicts increasing inflammation. |
| Q91659319 | The Added Value of Lactate and Lactate Clearance in Prediction of In-Hospital Mortality in Critically Ill Patients With Sepsis |
| Q35892267 | The MEST score provides earlier risk prediction in lgA nephropathy |
| Q92454424 | The distress thermometer as a prognostic tool for one-year survival among patients with lung cancer |
| Q38146916 | The potential of novel biomarkers to improve risk prediction of type 2 diabetes |
| Q47557279 | The tyranny of the averages and the indiscriminate use of risk factors in public health: The case of coronary heart disease |
| Q38395588 | Trabecular bone score (TBS) predicts vertebral fractures in Japanese women over 10 years independently of bone density and prevalent vertebral deformity: the Japanese Population-Based Osteoporosis (JPOS) cohort study. |
| Q35132382 | Urinary L-FABP predicts poor outcomes in critically ill patients with early acute kidney injury |
| Q47111536 | Urinary endotrophin predicts disease progression in patients with chronic kidney disease |
| Q34088928 | Urine YKL-40 is associated with progressive acute kidney injury or death in hospitalized patients |
| Q30917192 | Use of assisted reproductive technology treatment as reported by mothers in comparison with registry data: the Upstate KIDS Study. |
| Q34559814 | Using self-reported health measures to predict high-need cases among Medicaid-eligible adults |
| Q41206854 | Using temporal orientation, category fluency, and word recall for detecting cognitive impairment: the 10-point cognitive screener (10-CS). |
| Q64975690 | VEGF-C and Mortality in Patients With Suspected or Known Coronary Artery Disease. |
| Q89532777 | Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity |
| Q36176018 | Weighted Genetic Risk Scores and Prediction of Weight Gain in Solid Organ Transplant Populations |
| Q44249154 | What to expect from net reclassification improvement with three categories |
| Q38553935 | Will the future lie in multitude? A critical appraisal of biomarker panel studies on prediction of diabetic kidney disease progression |
Search more.